Potent synergistic combination of rosuvastatin and levofloxacin against Staphylococcus aureus: in vitro and in vivo study

Abdelaziz A. A.; El-Barrawy M. A.; El-Nagar R. A. M.

首页> 外文期刊>Journal of applied microbiology >Potent synergistic combination of rosuvastatin and levofloxacin against Staphylococcus aureus: in vitro and in vivo study

【24h】

Potent synergistic combination of rosuvastatin and levofloxacin against Staphylococcus aureus: in vitro and in vivo study

机译：罗苏伐他汀和左氧氟沙星对金黄色葡萄球菌的强大协同组合：体外和体内研究

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Aims The present study aims to evaluate the capability of rosuvastatin to synergize with levofloxacin against Staphylococcus aureus.

机译：目的本研究旨在评估瑞舒伐他汀与左氧氟沙星协同抗金黄色葡萄球菌的能力。

著录项

来源
《Journal of applied microbiology》 |2021年第1期|共15页
作者
Abdelaziz A. A.; El-Barrawy M. A.; El-Nagar R. A. M.;
展开▼
作者单位

Tanta Univ Fac Pharm Dept Pharmaceut Microbiol Tanta Egypt;

Alexandria Univ High Inst Publ Hlth HIPH Dept Med Microbiol Alexandria Egypt;

Tanta Univ Fac Pharm Dept Pharmaceut Microbiol Tanta Egypt;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类应用微生物学;
关键词
biofilms; levofloxacin; resistance; rosuvastatin; staphylococci; virulence;

机译：生物膜;左氧氟沙星;抗性;roosuvastatin;葡萄球菌;毒力;
入库时间 2022-08-20 19:51:43

相似文献

外文文献
中文文献
专利

1. In vitro and in vivo activity of D-serine in combination with β-lactam antibiotics against methicillin-resistant Staphylococcus aureus [J] . Qing Wang1, Yuemeng Lv1, Jing Pang1, 药学学报：英文版 . 2019,第003期
2. In vitro and in vivo activity of D-serine in combination with β-lactam antibiotics against methicillin-resistant Staphylococcus aureus [J] . Qing Wang, Yan Q.Xiong, Jiandong Jiang, 药学学报（英文版） . 2019,第003期
3. Anti-viral activity of Staphylococcus aureus lysates against herpes simplex virus type-Ⅰinfection:an in vitro and in vivo study [J] . Tian-Lan Lin, Chao Cheng, Wei-Ting Zeng, 国际眼科杂志：英文版 . 2021,第010期
4. Nanoemulsion containing a synergistic combination of curcumin and quercetin for nose-to-brain delivery: In vitro and in vivo studies [J] . Hitendra S Mahajan, Nayana D Patil 亚太热带生物医学杂志（英文版） . 2021,第011期
5. Nanoemulsion containing a synergistic combination of curcumin and quercetin for nose-to-brain delivery:In vitro and in vivo studies [J] . Hitendra S Mahajan, Nayana D Patil 亚太热带生物医学杂志：英文版 . 2021,第011期
6. In vitro and in vivo assessment of linezolid combined with ertapenem: a highly synergistic combination against methicillin-resistant Staphylococcus aureus. [J] . Jacqueline C, Caillon J, Grossi O, Antimicrobial agents and chemotherapy. . 2006,第7期

机译：利奈唑胺联合厄他培南的体外和体内评估：对耐甲氧西林的金黄色葡萄球菌具有高度协同作用的组合。
7. [J] . Anish Parmar, Rajamani Lakshminarayanan, Abhishek Iyer, Journal of Medicinal Chemistry . 2018,第5期

机译：<！[CDATA [CDATA [CDATA [CDATA（CDATA）对抗金黄色葡萄球菌的高效曲调脱蛋白类似物，耐甲氧西林抗性金黄色葡萄球菌（MRSA），和万古霉素耐药肠道（VRE）体内体外和]]>

8. Novel antiseptic compound OPB-2045G shows potent bactericidal activity against methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus both in vitro and in vivo: a pilot study in animals [J] . Yasuhide Inoue, Akifumi Hagi, Takuya Nii, Journal of Medical Microbiology: An Official Journal of the Pathological Society of Great Britain and Ireland . 2015,第1期

机译：新型抗菌化合物OPB-2045G在体内和体外均显示出对耐甲氧西林金黄色葡萄球菌和耐万古霉素肠球菌的有效杀菌活性：一项在动物中的初步研究

9. Synergistic Antibacterial Activities of Bioactive Compounds from Streptomyces sp. RS2 in Combination with Vancomycin against Staphylococcus aureus [C] . Nongyao Nonpanya, Suwanna Niamsanit, Kwanjai Kanokmedhakul, IEEE International Conference on Engineering Technologies and Applied Sciences . 2018

机译：链霉菌属生物活性化合物的协同抗菌活性。 RS2联合万古霉素抗金黄色葡萄球菌

10. Influence of in vitro bacterial urokinase responsiveness on the in vivo pathogenesis of methicillin-sensitive Staphylococcus aureus and methicillin-resistant Staphylococcus aureus in mouse models. [D] . Yanke, Shawna Janine. 2000

机译：体外细菌尿激酶反应性对小鼠模型中甲氧西林敏感的金黄色葡萄球菌和耐甲氧西林的金黄色葡萄球菌的体内发病机理的影响。

11. Systemic thioridazine in combination with dicloxacillin against early aortic graft infections caused by Staphylococcus aureus in a porcine model: In vivo results do not reproduce the in vitro synergistic activity [O] . Michael Stenger, Carsten Behr-Rasmussen, Kasper Klein, 2012

机译：全身性硫代哒嗪与双氯西林联用对猪模型中由金黄色葡萄球菌引起的早期主动脉移植物感染：体内结果未重现体外协同活性

12. Systemic thioridazine in combination with dicloxacillin against early aortic graft infections caused by Staphylococcus aureus in a porcine model: In vivo results do not reproduce the in vitro synergistic activity. [O] . Michael Stenger, Carsten Behr-Rasmussen, Kasper Klein, 2017

机译：系统性甲硫哒嗪与双氯西林联合治疗猪模型中由金黄色葡萄球菌引起的早期主动脉移植物感染：体内结果不能再现体外协同活性。

13. Staphylococcus aureus Biofilms Decrease Osteoblast Viability, Inhibits Osteogenic Differentiation, and Increases Bone Resorption in vitro. [R] . Sanchez, J., Ward, C. L., Romano, D. R., 2013

机译：金黄色葡萄球菌生物膜降低成骨细胞活力，抑制成骨分化，并增加体外骨吸收。

1. SYNTHESIS,CHARACTERIZATION OF CdTe QUANTUM DOTS & CdTe@SiO2 NANOPARTICLES AND THEIR TOXICITY STUDIES IN VITRO AND IN VIVO [A] . 阿诗玛 . 2013

1. composition; pharmaceutical composition; combination therapy; medical apparatus; method for administering at least one glycylcycline and at least one heparin; method for the administration of glycylcycline and heparin; method of treating intraabdominal infections with complications (ciai) and cutaneous infections and complications of the cutaneous structure (csssi) caused by gram negative and gram positive pathogens, anaerobic and methicillin-resistant strains and those resistant to staphylococcus aureus ( mssa and mrsa); method of treating intraabdominal infections with complications (ciai) and infections of the cutaneous and complicating skin structure (csssi) caused by gram negative and gram positive pathogens, anaerobic and methicillin-resistant strains of staphylococcus aureus ( mssa and mrsa) in a patient in need; antibiotic administration method; article of manufacture; kit; use of a glycylcillin of formula I or a pharmaceutically acceptable salt thereof; use of a heparin or pha [P] . 外国专利： BRPI0611070A2 . 2010-08-03

机译：组成;药物组合物;联合疗法医疗器械至少一种缩水甘油环素和至少一种肝素的给药方法;甘氨酰环素和肝素的给药方法;治疗由革兰氏阴性和革兰氏阳性病原体，厌氧和耐甲氧西林的菌株以及对金黄色葡萄球菌有抵抗力的菌株（mssa和mrsa）引起的合并症（ciai）和腹腔内感染的并发症（ciai）和皮肤感染以及皮肤结构并发症（csssi）;革兰氏阴性和革兰氏阳性病原体，金黄色葡萄球菌厌氧和耐甲氧西林菌株（mssa和mrsa）引起的并发症（CIAI）和皮肤感染和皮肤复杂结构（CSSS）感染的腹腔内感染的治疗方法;抗生素给药方法;制品;套件式I的糖基西林或其药学上可接受的盐的用途;肝素或相的使用

2. Use of Staphylococcus aureus protein 5G1 or 5H1 to assay biological samples in vitro for the presence of antibodies produced as a result of a S. aureus or S. epidermidis infection on implants [P] . 外国专利： FR2908889A1 . 2008-05-23

机译：使用金黄色葡萄球菌蛋白5G1或5H1体外分析生物样品中是否存在由于金黄色葡萄球菌或表皮葡萄球菌感染植入物而产生的抗体

3. Use of Staphylococcus aureus protein 5G1 to assay biological samples in vitro for the presence of antibodies produced as a result of a S. aureus or S. epidermidis infection on implants [P] . 外国专利： FR2908890A1 . 2008-05-23

机译：使用金黄色葡萄球菌蛋白5G1体外分析生物样品中是否存在由于金黄色葡萄球菌或表皮葡萄球菌感染植入物而产生的抗体

相关主题

Potent synergistic combination of rosuvastatin and levofloxacin against Staphylococcus aureus: in vitro and in vivo study

摘要

著录项

相似文献

相关主题

期刊订阅